Vendor review
Wuhan Wansheng Biotechnology reviews
Wuhan Wansheng Biotechnology reviews from 263 independent lab tests (Retatrutide, Tirzepatide and Tesamorelin): grade A, purity and fill accuracy. Is Wuhan Wansheng Biotechnology legit? See what its vials showed.
What the lab tests show
263 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | Retatrutide | 99.9 % | 21.8 mg of 20 mg (9 %) | Pass | View |
| Oct 8, 2026 | TB-500 | 99.9 % | 26.9 mg of 20 mg (35 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 9.2 mg of 10 mg (-8 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 47.1 mg of 50 mg (-6 %) | Pass | View |
| Sep 18, 2026 | TB-500 | 20 mg | Fail | View | |
| Sep 18, 2026 | BPC-157 | 97.88 % | 18.33 mg of 20 mg (-8 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 60 mg | Fail | View | |
| Sep 16, 2026 | Retatrutide | 99.9 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Sep 5, 2026 | Retatrutide | 99.9 % | 16.9 mg of 15 mg (13 %) | Pass | View |
| Sep 4, 2026 | Ipamorelin | 98.2 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Sep 4, 2026 | Tirzepatide | 10 mg | Fail | View | |
| Sep 4, 2026 | Tesamorelin | 99.9 % | 9.56 mg of 10 mg (-4 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 9.26 mg of 10 mg (-7 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 57.2 mg of 60 mg (-5 %) | Pass | View |
| Aug 2, 2026 | Retatrutide | 99.9 % | 21.6 mg of 20 mg (8 %) | Pass | View |
| Jul 22, 2026 | Retatrutide | 99.6 % | 29 mg of 30 mg (-3 %) | Pass | View |
| Jul 17, 2026 | Retatrutide | 99.9 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Jul 17, 2026 | Ipamorelin | 98.8 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Jul 1, 2026 | Tirzepatide | 99.9 % | 58 mg of 60 mg (-3 %) | Pass | View |
| Jul 1, 2026 | Melanotan II | 99.9 % | 8.87 mg of 10 mg (-11 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.8 % | 9.3 mg of 10 mg (-7 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Jun 23, 2026 | TB-500 | 99.7 % | 18.3 mg of 20 mg (-9 %) | Pass | View |
| Jun 23, 2026 | BPC-157 | 99.3 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Jun 22, 2026 | Semaglutide | 99.9 % | 20.7 mg of 20 mg (3 %) | Pass | View |
| Jun 22, 2026 | Retatrutide | 99.9 % | 46.2 mg of 50 mg (-8 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.6 % | 23.8 mg of 30 mg (-21 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.7 % | 15.8 mg of 15 mg (5 %) | Pass | View |
| Jun 12, 2026 | GHK-Cu | 99.9 % | 94.9 mg of 100 mg (-5 %) | Pass | View |
| Jun 12, 2026 | Melanotan II | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| May 25, 2026 | Retatrutide | 99.9 % | 50.5 mg of 50 mg (1 %) | Pass | View |
| May 18, 2026 | Retatrutide | 99.6 % | 21.5 mg of 20 mg (8 %) | Pass | View |
| May 13, 2026 | GHK-Cu | 99.7 % | 51.3 mg of 50 mg (3 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 25.8 mg of 30 mg (-14 %) | Pass | View |
| May 6, 2026 | Tirzepatide | 99.9 % | 18 mg of 20 mg (-10 %) | Pass | View |
| May 6, 2026 | Retatrutide | 99.9 % | 31.5 mg of 30 mg (5 %) | Pass | View |
| May 6, 2026 | BPC-157 | 99.3 % | 19.98 mg of 20 mg (0 %) | Pass | View |
| May 6, 2026 | Cagrilintide | 99.9 % | 4.3 mg of 5 mg (-14 %) | Pass | View |
| May 5, 2026 | Tirzepatide | 99.9 % | 27.1 mg of 30 mg (-10 %) | Pass | View |
| Apr 28, 2026 | Tesamorelin | 98.9 % | 4.94 mg of 5 mg (-1 %) | Pass | View |
| Apr 28, 2026 | Ipamorelin | 99.2 % | 4.92 mg of 5 mg (-2 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 29 mg of 30 mg (-3 %) | Pass | View |
| Apr 23, 2026 | Tesamorelin | 98.7 % | 5.27 mg of 5 mg (5 %) | Pass | View |
| Apr 23, 2026 | Tesamorelin | 89.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Apr 23, 2026 | BPC-157 | 99.9 % | 9.72 mg of 10 mg (-3 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.2 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 25, 2026 | TB-500 | 99.6 % | 13.4 mg of 10 mg (34 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.9 % | 32.1 mg of 100 mg (-68 %) | Pass | View |
| Mar 18, 2026 | Tirzepatide | 95.9 % | 10 mg of 10 mg (0 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 44 mg of 50 mg (-12 %) | Pass | View |
| Mar 12, 2026 | Tirzepatide | 99.9 % | 59.5 mg of 50 mg (19 %) | Pass | View |
| Mar 10, 2026 | TB-500 | 99.9 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| Mar 10, 2026 | GHK-Cu | 99.9 % | 52.9 mg of 50 mg (6 %) | Pass | View |
| Mar 10, 2026 | BPC-157 | 99.9 % | 9.97 mg of 10 mg (0 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 45.5 mg of 50 mg (-9 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 52.6 mg of 60 mg (-12 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 25.5 mg of 30 mg (-15 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 13.6 mg of 15 mg (-9 %) | Pass | View |
| Mar 6, 2026 | TB-500 | 99.9 % | 9.27 mg of 10 mg (-7 %) | Pass | View |
What Wuhan Wansheng Biotechnology sells
No current listings on record.
About Wuhan Wansheng Biotechnology
DO NOT purchase from wuhanwanshengbio.com: evidence of fraud, verify from a trusted source that you are purchasing from the legitimate vendor, and not from a fake site.